Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 8, Pages 1123-1140
Publisher
Informa Healthcare
Online
2014-05-16
DOI
10.1517/13543784.2014.918603
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Δ9-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18
- (2014) Douglas McHugh et al. Frontiers in Pharmacology
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- Selective CB2 agonists with anti-pruritic activity: Discovery of potent and orally available bicyclic 2-pyridones
- (2013) Ken-ichi Kusakabe et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1Areceptors without diminishing nervous system function or chemotherapy efficacy
- (2013) Sara Jane Ward et al. BRITISH JOURNAL OF PHARMACOLOGY
- In vivocharacterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects
- (2013) B M Ignatowska-Jankowska et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia
- (2013) Jarkko Kalliomäki et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
- (2013) Tapio Nevalainen CURRENT MEDICINAL CHEMISTRY
- Mastering tricyclic ring systems for desirable functional cannabinoid activity
- (2013) Ravil R. Petrov et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?
- (2013) Katarzyna Starowicz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
- (2013) A.-L. Klauke et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases
- (2013) Ioanna Vasileiou et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research
- (2013) Naihua Duan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
- (2013) Sangdon Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain
- (2013) Sean P. Hollinshead et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
- (2013) Israel Matos et al. MOLECULAR IMMUNOLOGY
- Differential Modulation of Nociceptive versus Non-Nociceptive Synapses by Endocannabinoids
- (2013) Alexandra Higgins et al. Molecular Pain
- Analgesic Effect of a Mixed T-Type Channel Inhibitor/CB2 Receptor Agonist
- (2013) Vinicius M Gadotti et al. Molecular Pain
- The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice
- (2013) J. Fichna et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors
- (2013) Francisco Espejo-Porras et al. NEUROPHARMACOLOGY
- More surprises lying ahead. The endocannabinoids keep us guessing
- (2013) Daniele Piomelli NEUROPHARMACOLOGY
- Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors
- (2013) Julie Desroches et al. NEUROPHARMACOLOGY
- Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice
- (2013) H. Ikeda et al. NEUROSCIENCE
- The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain
- (2013) M.L. Uhelski et al. NEUROSCIENCE
- Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy
- (2013) J.J. Xu et al. NEUROSCIENCE
- The known knowns of microglia–neuronal signalling in neuropathic pain
- (2013) Simon Beggs et al. NEUROSCIENCE LETTERS
- Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models
- (2013) Fabrizio Vincenzi et al. PAIN
- Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as “dual-target” analgesics
- (2013) Sabatino Maione et al. PHARMACOLOGICAL RESEARCH
- Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain
- (2013) Jin Hua Cui et al. PHARMACOLOGY
- Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation
- (2013) András Iring et al. PLoS One
- Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint
- (2013) James J. Burston et al. PLoS One
- “Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control
- (2012) Fabiana Piscitelli et al. ACS Chemical Neuroscience
- Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System
- (2012) Mohamed Naguib et al. ANESTHESIA AND ANALGESIA
- Novel Δ9-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects
- (2012) Linda E. Klumpers et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- GPR18 in microglia: implications for the CNS and endocannabinoid system signalling
- (2012) D McHugh BRITISH JOURNAL OF PHARMACOLOGY
- The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription
- (2012) RB Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide
- (2012) Paolo Ambrosino et al. BRITISH JOURNAL OF PHARMACOLOGY
- New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2
- (2012) Terry Kenakin BRITISH JOURNAL OF PHARMACOLOGY
- TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium–calcium exchangers in rat odontoblasts
- (2012) Maki Tsumura et al. CELL CALCIUM
- The Endocannabinoid System and Pain
- (2012) Josee Guindon et al. CNS & Neurological Disorders-Drug Targets
- Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception
- (2012) S. Katsuyama et al. EUROPEAN JOURNAL OF PAIN
- Selective cannabinoid receptor 2 modulators: a patent review 2009 – present
- (2012) Doris Riether EXPERT OPINION ON THERAPEUTIC PATENTS
- Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and GiProtein-independent ERK1/2 Kinase Activation
- (2012) Kwang H. Ahn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabinoid Receptors CB1and CB2Form Functional Heteromers in Brain
- (2012) Lucía Callén et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence for Bidirectional Endocannabinoid Transport across Cell Membranes
- (2012) Andrea Chicca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist
- (2012) Suneeta Tumati et al. JOURNAL OF NEUROIMMUNOLOGY
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- Spinal Cannabinoid Receptor Type 2 Agonist Reduces Mechanical Allodynia and Induces Mitogen-Activated Protein Kinase Phosphatases in a Rat Model of Neuropathic Pain
- (2012) Russell P. Landry et al. JOURNAL OF PAIN
- Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
- (2012) Russell K. Portenoy et al. JOURNAL OF PAIN
- An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
- (2012) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- In Vivo Efficacy of Enabling Formulations Based on Hydroxypropyl-β-Cyclodextrins, Micellar Preparation, and Liposomes for the Lipophilic Cannabinoid CB2 Agonist, MDA7
- (2012) Fanny Astruc-Diaz et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors
- (2012) Pingwei Zhao et al. LIFE SCIENCES
- COX-2 and PPAR- Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
- (2012) R. Ramer et al. MOLECULAR CANCER THERAPEUTICS
- CB2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons
- (2012) Brady K. Atwood et al. NEUROPHARMACOLOGY
- AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies
- (2012) Kathryn A. Seely et al. NEUROPHARMACOLOGY
- The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain
- (2012) Courtney Breen et al. NEUROSCIENCE LETTERS
- Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels
- (2012) Jenny L. Wilkerson et al. PAIN
- Inhibitors of endocannabinoid breakdown for pain: Not so FA(AH)cile, after all
- (2012) Vincenzo Di Marzo PAIN
- An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
- (2012) John P. Huggins et al. PAIN
- N-acylethanolamine acid amidase (NAAA), a new path to unleash PPAR-mediated analgesia
- (2012) Bradley K. Taylor PAIN
- Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models
- (2012) Oscar Sasso et al. PAIN
- Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
- (2012) Josée Guindon et al. PHARMACOLOGICAL RESEARCH
- Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system
- (2012) K. Starowicz et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
- (2012) R. G. Pertwee PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
- (2012) F. S. den Boon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia
- (2012) Jenny L. Wilkerson et al. Brain and Behavior
- Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyl-D-Aspartic Acid
- (2011) XiaoPing Gu et al. ANESTHESIA AND ANALGESIA
- CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain
- (2011) Iryna A. Khasabova et al. BEHAVIOURAL PHARMACOLOGY
- Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain
- (2011) Aldric Hama et al. BRAIN RESEARCH
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice
- (2011) Lamont Booker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones
- (2011) Alex Straiker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
- (2011) Douglas McHugh et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
- (2011) Nariman A B Balenga et al. CELL RESEARCH
- A Randomized, Controlled Study to Investigate the Analgesic Efficacy of Single Doses of the Cannabinoid Receptor-2 Agonist GW842166, Ibuprofen or Placebo in Patients With Acute Pain Following Third Molar Tooth Extraction
- (2011) Thor Ostenfeld et al. CLINICAL JOURNAL OF PAIN
- Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
- (2011) E L Karschner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Inhibition of Monoacylglycerol Lipase Attenuates Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Hemorrhages in Mice
- (2011) S. G. Kinsey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Interaction Between Intrathecal Administration of Low Doses of Palmitoylethanolamide and AM251 in Formalin-Induced Pain Related Behavior and Spinal Cord IL1-β Expression in Rats
- (2011) Nima Naderi et al. NEUROCHEMICAL RESEARCH
- Spinal anandamide produces analgesia in neuropathic rats: Possible CB1- and TRPV1-mediated mechanisms
- (2011) K. Starowicz et al. NEUROPHARMACOLOGY
- Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model
- (2011) Jin Hua Cui et al. NEUROSCIENCE LETTERS
- The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55
- (2011) Niklas Schuelert et al. NEUROSCIENCE LETTERS
- Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain
- (2011) Iryna A. Khasabova et al. PHARMACOLOGICAL RESEARCH
- Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
- (2011) Elizabeth J. Rahn et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice
- (2011) Steven G. Kinsey et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- CB2: Therapeutic target-in-waiting
- (2011) Brady K. Atwood et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
- (2010) Douglas McHugh et al. BMC NEUROSCIENCE
- The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation andin vitromotility disturbances in rat colitis
- (2010) JM Jamontt et al. BRITISH JOURNAL OF PHARMACOLOGY
- The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
- (2010) Daniele Bolognini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain
- (2010) Josée Guindon et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
- (2010) Sabatino Maione et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
- (2010) R. Pertwee CURRENT MEDICINAL CHEMISTRY
- The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment
- (2010) Rudolf Schicho et al. INFLAMMATORY BOWEL DISEASES
- Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors Produce Anti-Allodynic Effects in Mice Through Distinct Cannabinoid Receptor Mechanisms
- (2010) Steven G. Kinsey et al. JOURNAL OF PAIN
- Monoacylglycerol Lipase Activity Is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System
- (2010) P. K. Chanda et al. MOLECULAR PHARMACOLOGY
- Effect of the Cannabinoid Receptor-1 Antagonist Rimonabant on Inflammation in Mice With Diet-Induced Obesity
- (2010) Qun Wang et al. Obesity
- A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain
- (2010) Xiao Hong Yu et al. PAIN
- Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain
- (2010) David J. Hewitt et al. PAIN
- Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms
- (2010) Jessica M. Spradley et al. PHARMACOLOGICAL RESEARCH
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Cannabinoids and the gut: New developments and emerging concepts
- (2010) Angelo A. Izzo et al. PHARMACOLOGY & THERAPEUTICS
- R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids
- (2010) Philipp Bishay et al. PLoS One
- Endocannabinoid Signaling and Long-Term Synaptic Plasticity
- (2009) Boris D. Heifets et al. Annual Review of Physiology
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia
- (2009) Rita Nyilas et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Examining the roles of cannabinoids in pain and other therapeutic indications: a review
- (2009) Dana Turcotte et al. EXPERT OPINION ON PHARMACOTHERAPY
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
- (2009) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
- (2009) J. A. Przybyla et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
- (2009) S. G. Kinsey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Endocannabinoids Suppress Excitatory Synaptic Transmission to Dorsal Raphe Serotonin Neurons through the Activation of Presynaptic CB1 Receptors
- (2009) S. Haj-Dahmane et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia
- (2009) Devi Rani Sagar et al. Molecular Pain
- CANnabinoid Receptor Type 2 Activation Induces a Microglial Anti-Inflammatory Phenotype and Reduces Migration via MKP Induction and ERK Dephosphorylation
- (2009) Edgar Alfonso Romero-Sandoval et al. Molecular Pain
- Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
- (2009) Elizabeth J. Rahn et al. Neurotherapeutics
- Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain
- (2009) Eva Martín-Sánchez et al. PAIN MEDICINE
- Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
- (2009) C. Solorzano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms
- (2008) Carl Potenzieri et al. BRAIN RESEARCH
- Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model
- (2008) J Desroches et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity
- (2008) S Shu-Jung Hu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats
- (2008) Megan Ryan Detloff et al. EXPERIMENTAL NEUROLOGY
- 6-Methoxy-N-alkyl Isatin Acylhydrazone Derivatives as a Novel Series of Potent Selective Cannabinoid Receptor 2 Inverse Agonists: Design, Synthesis, and Binding Mode Prediction
- (2008) Philippe Diaz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Constitutive Activity at the Cannabinoid CB1 Receptor Is Required for Behavioral Response to Noxious Chemical Stimulation of TRPV1: Antinociceptive Actions of CB1 Inverse Agonists
- (2008) B. Fioravanti et al. JOURNAL OF NEUROSCIENCE
- Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain
- (2008) I. Racz et al. JOURNAL OF NEUROSCIENCE
- Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
- (2008) E. J. Rahn et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging
- (2008) B. B. Yao et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
- (2008) Jonathan Z Long et al. Nature Chemical Biology
- Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
- (2008) István Katona et al. NATURE MEDICINE
- The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
- (2008) Penny C. Staton et al. PAIN
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia
- (2008) Armen N. Akopian et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Rimonabant: more than an anti-obesity drug?
- (2007) B Costa BRITISH JOURNAL OF PHARMACOLOGY
- Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats
- (2007) T Croci et al. BRITISH JOURNAL OF PHARMACOLOGY
- The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action
- (2007) C J Fowler BRITISH JOURNAL OF PHARMACOLOGY
- Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
- (2007) E J Rahn et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Multiple pathways involved in the biosynthesis of anandamide
- (2007) Jie Liu et al. NEUROPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now